Gene m164 of murine cytomegalovirus belongs to the large group of 'private' genes that show no homology to those of other cytomegalovirus species and are thought to represent 'host adaptation' genes involved in virus-host interaction. Previous interest in the m164 gene product was based on the presence of an immunodominant CD8 T-cell epitope presented at the surface of infected cells, despite interference by viral immune-evasion proteins. Here, we provide data to reveal that the m164 gene product shows unusual features in its cell biology. A novel strategy of mass-spectrometric analysis was employed to map the N terminus of the mature protein, 107 aa downstream of the start site of the predicted open reading frame. The resulting 36.5 kDa m164 gene product is identified here as an integral type-I membrane glycoprotein with exceptional intracellular trafficking dynamics, moving within the endoplasmic reticulum (ER) and outer nuclear membrane with an outstandingly high lateral membrane motility, actually 100 times higher than those published for cellular ER-resident proteins. Notably, gp36.5/m164 does not contain any typical ER-retention/retrieval signals, such as the C-terminal motifs KKXX or KXKXX, and does not pass the Golgi apparatus. Instead, it belongs to the rare group of viral glycoproteins in which the transmembrane domain (TMD) itself mediates direct ER retention. This is the first report relating TMD usage of an ER-resident transmembrane protein to its lateral membrane motility as a paradigm in cell biology. We propose that TMD usage for ER retention facilitates free and fast floating in ER-related membranes and between ER subdomains. 3These authors contributed equally to this work. 
INTRODUCTION
Transmembrane proteins that are retained in the endoplasmic reticulum (ER) after folding are referred to as ERresident proteins. Other transmembrane proteins pass the Golgi apparatus and travel to the cell surface with the vesicular bulk flow or associate with adaptor proteins for cargo sorting into transport vesicles to reach their final destination in the cell. ER-resident proteins either avoid Golgi passage or are retrieved from the Golgi back to the ER. Localization to the ER usually depends on typical ER-retention or -retrieval signals located in the cytosolic C-terminal or N-terminal tail of type-I and type-II transmembrane proteins, respectively. The most common ER-retention/retrieval signal for soluble ER proteins is the C-terminal motif K/HDEL (Lys/His-Asp-Glu-Leu), which retains the protein in the ER through binding to any of the KDEL receptors known in mammalian cells (Pelham, 1995) . It is not yet clear whether the different receptors mediate different sub-ER localizations. C-terminal sequences for retrieval of type-I and type-III transmembrane proteins from the Golgi to the ER are characterized by the motifs KKXX or KXKXX (Jackson et al., 1990 ; reviewed by Pelham, 1995; Teasdale & Jackson, 1996) . Interestingly, KDEL and KKXX motifs appended to the same reporter protein were found to determine different protein-trafficking pathways (Stornaiuolo et al., 2003) . Cytosolic N-terminal RR (Arg-Arg) motifs are involved in the ER retention of type-II transmembrane proteins (Michelsen et al., 2005) . In the ER-resident chaperone calnexin, ER retention is mediated by an arginine-rich region at its cytosolic C terminus. Other mechanisms for ER retention are being studied, but are still incompletely understood. Specifically, there exist examples for transmembrane glycoproteins that use their transmembrane domain (TMD) for ER retention.
The list of viral transmembrane glycoproteins for which the TMD suffices for ER retention is quite limited ( Table 1) , suggesting that usage of the TMD for ER retention plays a distinctive role in the biology of these viruses. As discussed by Cocquerel et al. (1999) , retention of envelope glycoproteins E1 and E2 of hepatitis C virus through their respective TMDs may play a crucial role for virion envelope formation by retaining envelope glycoproteins for budding in the ER. Likewise, for the example of the envelope glycoproteins prM and E of yellow fever virus (YFV), Op De Beeck et al. (2004) also discussed a role for TMD-mediated ER retention in accumulating these proteins in the ER, the compartment where budding of YFV takes place. Whilst TMDs mediating ER retention were previously known only for two families of positive-sense, single-stranded RNA viruses, namely Flaviviridae, genera Flavivirus and Hepacivirus, and Togaviridae, genus Rubivirus (Table 1) , a herpesviral glycoprotein was added to the list only recently (Ashiru et al., 2009) , namely the human cytomegalovirus (hCMV) glycoprotein UL142 (Table 1) , which is involved in natural killer (NK) cell evasion in that it retains the NK receptor NKG2D ligand MICA in a cis-Golgi compartment.
Why some ER-resident transmembrane proteins have evolved to avoid motif-mediated interaction with retention receptors, but instead use the TMD directly, is currently unexplored. An intriguing idea is that lack of constitutive anchoring at retention receptors might facilitate a free lateral floating in the ER membranes in the absence of other interaction partners. To our knowledge, TMD usage for ER retention has not yet been related in the literature to lateral membrane motility for any transmembrane protein.
Here, we provide an example of a viral type-I glycoprotein, namely the gene product gp36.5/m164 of the murine cytomegalovirus (mCMV) open reading frame (ORF) m164, that localizes to the ER and outer nuclear membrane (ONM) by using its TMD for ER retention. Interestingly, this glycoprotein moves in the ER membranes as fast as soluble proteins move in the cytosol and 100 times faster than has been measured so far for any other ER membrane protein.
RESULTS AND DISCUSSION

Identification of the ORFm164 gene product
Our only previous knowledge about ORFm164, besides its established role as the source of an immunodominant antigenic peptide (Holtappels et al., 2002a, b) , was based on the nucleotide sequence of the mCMV Smith strain genome, here referred to as mCMV-WT.Smith, determined by Rawlinson et al. (1996) . The sequence predicted a type-III transmembrane glycoprotein with a protein moiety comprising 427 aa residues with a calculated molecular mass of 46.6 kDa. Surprisingly, when we attempted to verify the predicted 46.6 kDa gene product biochemically in protein extracts of cells infected with mCMV-WT.Smith and haemagglutinin (HA) peptide-tagged recombinant virus mCMV-m164HA-C, molecular species of 36.5 kDa and HA-tagged 37.5 kDa, respectively, were identified (Fig. 1a, left panel) . Likewise, a C-terminally V5-tagged 37.5 kDa product was detected in whole-cell lysate protein extract of COS-7 cells transiently transfected with an m164V5-C expression plasmid. Reduction of its apparent molecular mass to 35.5 kDa upon peptidyl-N-glycosidase F (PNGase F) treatment indicated the presence of a single 2 kDa N-glycosylation moiety in a tag-subtracted 36.5 kDa glycoprotein (Fig. 1a , centre panel). It should be noted that antiserum directed against an N-terminal peptide deduced from the predicted ORFm164 did not detect any product (data not shown), which gave us a first hint of a possibly missing N-terminal sequence.
Determination of the N terminus of gp36.5/m164 by mass spectrometry
To resolve the discrepancy between the predicted molecular mass of 48.6 kDa (glycosylation included) and the observed molecular mass of 36.5 kDa, we sought to identify the N terminus of the mature glycoprotein directly by mass spectrometry (MS) (see Supplementary Fig. S1 , available in JGV Online). For this, we applied a novel strategy for database searching. Standardized databaseassisted identification schemes for MS spectra derived from tryptic digests are restricted to tryptic peptides, thereby minimizing false-positive peptide identification. Peptides generated by peptidases other than trypsin alone, however, will not be identified. To circumvent this problem and to identify the N terminus of the mature protein, which we hypothesized to be generated by signal peptide peptidase cleavage, we generated a database supplemented with Nterminally truncated versions of the predicted m164 protein. After transfection of COS-7 cells, HA-tagged gp37.5 was purified by immunomagnetic enrichment and gel electrophoresis, and was subjected to in-gel digestion with trypsin followed by MS. By automated data processing and interpretation of the fragment spectra using the PLGS software, we obtained a sequence coverage of 58 % in the region of aa 126-414 based on the sequence of the originally predicted ORFm164-Rawlinson. As we detected no tryptic fragments derived from the predicted Nterminal region of the protein, we performed signal peptide peptidase cleavage-site predictions using SignalP 3.0 (Bendtsen et al., 2004) for three putative polypeptides defined by the alternative start sites Met1, Met27 and Met91. A positive result was obtained only for the polypeptide starting at Met91, with a predicted signal peptidase cleavage site located between Ala107 and Ser108. As our initial automated database search, which was directed to identify tryptic peptides only, did not reveal the predicted protein start site, we supplemented our database with additional, N-terminally truncated versions of m164 starting at positions aa 1-120. With this extended database, we identified peptide 108-SAVGSCVDGVLSDNCMNK-125, which was apparently produced by an N-terminal signal peptidase cleavage and a C-terminal tryptic cleavage.
Membrane topology of gp36.5/m164 determined by glycosylation-site mapping
As N-glycosylation takes place in the lumenal compartment, usage of the two predicted N-glycosylation sites Asn311 and Asn193 that flank the predicted TMD aa 251-273 is mutually exclusive. To determine the topology of gp36.5/ m164, the single N-glycosylation site was mapped by transient transfection of COS-7 cells with m164HA-C expression plasmids carrying mutation N311Q or N193Q. Western blotting using anti-HA-tag antibodies revealed a 2 kDa molecular mass shift from 37.5 to 35.5 kDa specifically for the N193Q mutation (Fig. 1a , right panel), which identified Asn193 as the single N-glycosylation site in a type-I glycoprotein.
Altogether, these findings show that a primary translation product p36 starts at Met91 of the originally predicted sequence. Upon translocation into the ER, cleavage by the signal peptide peptidase removes the N-terminal 17 aa signal peptide 91-MLALIYAAASAAGTASA-107 to generate a 320 aa p34.5 intermediate starting with Ser1 (previously Ser108). Finally, glycosylation at Asn193 (previously Asn300) generates the mature form gp36.5 (Fig. 1b, c) .
Identification of gp36.5/m164 as an early (E)-phase protein
The expression of gp36.5/m164 in mouse embryo fibroblasts (MEFs) infected with mCMV-WT.Smith was determined by Western blot analysis using anti-m164 C-terminal peptide antibodies. The time-course of its expression ( Fig. 2a ) and its absence under conditions of enhanced and selective immediate-early (IE) protein synthesis ( Fig. 2b ) identified gp36.5/m164 as an E-phase protein that becomes detectable between 2 and 3 h post-infection and remains present in the late (L) phase beyond 16 h post-infection.
Glycoprotein gp36.5/m164 does not pass the Golgi apparatus
As a first approach to identify the intracellular distribution of gp36.5/m164, subcellular fractionation studies based on organelle densities were performed using COS-7 cells transfected with a pcDNA3.1-based plasmid expressing m164HA-C. Western blot analysis with anti-HA tag antibodies detected the 37.5 kDa HA-tagged m164 protein in the ER and in ER compartment-related fractions, but not in fractions representing the Golgi apparatus or exosomes and endosomes (Fig. 3a) . In accordance with this, after infection of MEFs with mCMV-WT.Smith, the 2 kDa carbohydrate moiety at Asn193 proved to be sensitive to endoglycosidase H (Endo H), as indicated by a shift from 36.5 to 34.5 kDa (Fig. 3b) . Finally, confocal laser-scanning microscopic (CLSM) fluorescence analysis of mCMV-WT.Smith-infected MEFs with antibodies directed against gp36.5/m164 and the cis-Golgi compartment-specific marker GM130 showed that gp36.5/m164 does not colocalize with the Golgi apparatus ( Fig. 4a) . Sensitivity to Endo H and absence in Golgi membrane fractions, as well as lacking colocalization with the cis-Golgi marker GM130 and the trans-Golgi network (TGN) marker TGN38 (see below), indicated that gp36.5/m164, at least the bulk of it, does not pass the Golgi. In addition, CLSM analysis did not indicate a punctate fluorescence, as one would expect for proteins contained in transport vesicles, but revealed a reticular distribution that is characteristic of ER residence. (Fig. 4b , bottom row; optical section focused on the nuclear rim) revealed its localization to both the ER and the nuclear rim. At this stage of the work, we therefore considered the possibility that gp36.5/m164, in addition to its presence in the ER, might be located in the INM, possibly interacting with emerin for playing a putative role in viral nucleocapsid egress. This speculation, however, was not supported by fluorescence resonance energy transfer (FRET) analysis, which did not reveal an interaction between gp36.5/m164 and emerin (data not shown). Here, we did not specifically address the question of whether gp36.5/m164, like hCMV UL37 proteins (Bozidis et al., 2007; Mavinakere et al., 2006) , might also localize to the mitochondria-associated membranes, a tubular subdomain of the ER that provides physical contact between the ER and mitochondria for lipid and ceramide transfer.
Fluorescence recovery after photobleaching (FRAP) analysis revealing a high motility of gp36.5/m164 in the ER and the ONM An obvious explanation for the failure of FRET between emerin and gp36.5/m164 at the nuclear rim could be a localization of gp36.5/m164 to the ONM, as the 10-40 nm distance caused by the perinuclear space precludes FRET, which takes place only when the distance between molecules is ,10 nm. The ONM is continuous with the ER and can be reached easily from there by lateral diffusion. Nonetheless, it is a distinct, specialized membrane compartment to which not all ER membrane proteins localize uniformly (Wilhelmsen et al., 2005; Worman & Gundersen, 2006) . FRAP analysis is the method of choice to determine lateral membrane motility of integral membrane proteins. High motility in the ONM and the ER leads to fast FRAP, whereas in the INM, recovery is slow due to hindrance by the network that INM proteins form with the nuclear lamina and the chromatin (reviewed by Houtsmuller & Vermeulen, 2001 ). The typical half-lives (t K ) of fluorescence recovery for INM proteins are reported to range between 60 and 100 s (Shimi et al., 2004) ; t K is 60 s for the specific example of emerin-EGFP (enhanced green fluorescent protein) (Ö stlund et al., FRAP analysis of lateral membrane motility was performed with COS-7 cells transfected with an expression plasmid encoding the fusion protein gp36.5/m164-EGFP (Fig. 5) . The speed of FRAP was compared for gated regions of the same size and shape at the nuclear rim ( Fig. 5a ) and in the ER (Fig. 5b) . We measured t K values of 3.5±2.1 and 3.5±1.7 s (mean±SD), respectively. This corresponds to diffusion coefficients of approximately 15 mm 2 s 21 at both subcellular locations, which is two orders of magnitude higher than for emerin-EGFP present in the INM. As motilities of different membrane proteins vary in their absolute t K and D values, irrespective of their localization, the most important criterion for distinguishing between localization to the INM or ONM is the comparison with the ER data. So, a motility similar to that in the ER argues strongly for localization to the ONM, whereas a distinctively lower motility would have argued for INM. Clearly, D values for gp36.5/m164 at the nuclear rim and in the ER were not different (Fig. 5 ). In conclusion, gp36.5/m164 is a type-I glycoprotein that localizes to the ER and ONM.
Beyond the decision regarding the precise sublocalization at the nuclear rim, the FRAP data revealed remarkably high Fig. 3 . Identification of gp36.5/m164 as an ER-resident glycoprotein not passing the Golgi apparatus. (a) Velocity-guided sucrose-gradient fractionation of COS-7 cells transfected with plasmid pcDNA3.1m164HA_C expressing C-terminally HAtagged 37.5 kDa m164 glycoprotein. Western blot analysis was performed with antibodies directed against the HA tag and the ER marker proteins furin and calnexin. N, Nuclear fraction; P, pellet. (b) Whole-cell protein lysate derived from MEFs 6 h after infection with mCMV-WT.Smith was either left untreated (") or was deglycosylated (+) with enzymes PNGase F (PF) or Endo H. Shown is a Western blot analysis performed with a-m164 antibodies. . Even if we consider methodological variances in the determination of D values, these comparisons help to evaluate the motility of gp36.5/m164 at least in terms of the order of magnitude. Clearly, it moves much faster than an average ER membrane protein, actually about 100-fold as fast, suggesting that it floats without any significant hindrance by interaction partners. In this context, it may be informative to note that a yeast two-hybrid screening with a mouse cDNA library did indeed not reveal any cellular interaction partner (negative data not shown).
The TMD of gp36.5/m164 serves as an ER-retention signal on its own ER-resident proteins that are retained in the ER through ER-retention motifs recognized by cognate ER-retention receptors (see Introduction) ought to be expected to move as a complex more slowly in the ER membranes, dependent upon the lateral membrane motility of their corresponding receptors. Interestingly, the 320 aa sequence of gp36.5 does not contain any known ER-retention or -retrieval signals in its cytoplasmic C-terminal tail. Therefore, its ER retention must be mediated either by a novel motif or by the TMD itself. Its extraordinarily high lateral membrane motility argued in favour of the second alternative. To provide experimental evidence for this, we tested the capacity of the TMD sequence to mediate ER retention of full-length or partitioned m164-EGFP fusion proteins by CLSM fluorescence analysis of COS-7 cells transfected with the corresponding expression plasmids (Fig. 6) .
At a glance, absence and presence of the TMD in the fusion proteins defined two distinct, markedly different patterns of intracellular distribution (Fig. 6a, c, d , e versus Fig. 6b, f,  g, h) . Specifically, expression of EGFP alone resulted in a combined cytoplasmic and intranuclear distribution (Fig.  6a) . In contrast, and as expected from the preceding experiments, the complete m164-EGFP fusion protein fA-TMD-fB-EGFP, with fA and fB representing the TMDflanking N-and C-terminal m164 protein fragments, respectively, showed an ER-typical reticular fluorescence pattern (Fig. 6b) . Excision of the TMD in fusion protein fA-fB-EGFP ablated the ER retention (Fig. 6c) , thus indicating that the TMD is required for ER retention. Accordingly, fusion proteins fA-EGFP and fB-EGFP also showed a distribution similar to that of EGFP (Fig. 6d, e,  respectively) . Notably, the TMD sequence mediated ER retention of fB-containing EGFP fusion proteins, regardless of whether EGFP was positioned N-terminally or C-terminally of TMD-fB (Fig. 6f, g, respectively) . The latter configuration is particularly interesting, as here the TMD is displaced to the N terminus and thus can no longer mediate a transmembranal insertion of the fusion protein, but can at most fix it to the membrane. ER localization of this construct thus revealed that the ectodomain is dispensable for ER retention. We wondered whether ER retention relates to the immunological properties of the protein, but cells transfected with constructs containing fA (corresponding to Fig. 6b-d) , which includes the D d -restricted antigenic peptide (recall Fig. 1b) , were all able to stimulate cognate CD8 T cells, regardless of the intracellular localization of the protein (data not shown).
Thus far, the data have shown that the TMD is required, but a contribution of amino acids within fB was not excluded. That the TMD is indeed sufficient for mediating ER retention was finally shown by linking it directly to EGFP in fusion protein EGFP-TMD (Fig. 6h) .
Concluding remarks
With this work, we have identified a novel TMD sequence that is sufficient to mediate ER retention. Strikingly, currently known examples for viral proteins listed in Table  1 do not reveal common sequence motifs. Positively charged residues were previously discussed to play a role (Boyd & Beckwith, 1990) , but this does not appear to apply to the TMDs of rubella virus E1, hCMV UL142 or mCMV gp36.5/m164. We have provided here a paradigm linking exclusive TMD usage for ER retention to high lateral Fig. 6 . Verification of the TMD and its function as an ER-retention signal. COS-7 cells were transfected with plasmids expressing EGFP (green) either alone (a) or fused to the C terminus of full-length m164 protein (b), or fused to constructs lacking (c, d, e) or containing (f, g, h) the TMD, as is illustrated schematically on top of the CLSM fluorescence images (59/N terminus to the left and 39/C terminus to the right; not drawn to scale). The TMD is represented by a black box, EGFP by a green box, and the signal peptide by a dotted box. Ectodomain and cytosolic domain, flanking the TMD in the full-length protein, are labelled A and B, respectively. Nuclei were stained with Hoechst dye (blue). Images represent optical sections (single Z slices). Bar, 10 mm. membrane motility. It remains to be established whether such a proposed relationship holds true for the other examples of exclusive TMD usage. Such data are currently missing in the literature, as studies on TMD usage are not usually combined with the technically demanding FRAP analysis of lateral membrane motility. The functional role in virus biology, as well as in cell biology in general, is still open to question. One possibility might be that lack of specific cytoplasmic motifs makes the protein independent of the localization of retention receptors and thus enables it to traffic freely between all ER subdomains. Although the speculated role in the envelopment of viruses at ER membranes has been intriguing for envelope glycoproteins (see Introduction), this explanation does apparently not apply to the TMDs of hCMV UL142 and mCMV gp36.5/ m164, as these cytomegaloviral glycoproteins are not constituents of the respective virion envelopes (Streblow et al., 2006) .
METHODS
Cell culture, transfection and infection. COS-7 cells were grown in Dulbecco's modified Eagle's medium (catalogue no. 61965; Invitrogen) containing 10 % fetal calf serum. Transient transfection was performed with PolyFect transfection reagent (catalogue no. 301107; Qiagen). Transfection efficiencies were approximately 30 % after 48 h. MEFs were prepared as described previously (Podlech et al., 2002) 
Construction of expression vectors and site-directed mutagenesis
Sequences of primers for cloning and mutagenesis are listed in Supplementary Table S1 (available in JGV Online).
Determination of the N-glycosylation site. For appending a V5 tag to the C terminus, gene m164 was amplified by PCR from mCMV-WT.Smith virion DNA as template with primers pcDNA3.1_rev and pTracerEF_for. The resulting m164 amplimer was cloned via the EcoRI/XbaI restriction sites into the expression vector pTracer-EF/V5-His A (catalogue no. V887-01; Invitrogen). To identify the position of the single N-glycosylation site, plasmid pcDNA3.1m164HA_C was constructed by cloning the m164-specific sequence into the pcDNA3.1myc/His vector (catalogue no. V800-20; Invitrogen). Instead of using the internal myc/His tag, however, an HA tag including a stop codon was appended via PCR with the respective primer pcDNA3.1HA_rev. Primer pcDNA3.1_for, including a start codon as well as a Kozak sequence, was used as forward primer. Two independent inserts were constructed for replacing Asn (codon AAC) with Gln (codon CAA) at both in silicopredicted N-glycosylation sites. The point mutation N193Q was generated with plasmid pcDNA3.1m164HA_C as template DNA via site-directed mutagenesis by overlap-extension PCR (Ho et al., 1989) with primers SMD_193_new_for and SMD_193_new_rev, as well as SMD_193_new_revII and SMD_311_new_for. In the subsequent fusion reaction, primers SMD_193_new_revII and SMD_311_new_for were used. For introducing mutation N311Q, SMD_311_new_for and SMD_311_new_rev were used as primers and pcDNA3.1m164HA_C as template. All PCRs were performed with the following cycling conditions using Phusion High-Fidelity DNA polymerase [catalogue no. F553L; New England Biolabs (NEB)]: an initial step for 2 min at 95 uC, followed by 30 cycles for 30 s at 95 uC, 30 s at 60 uC (or 15 s in the fusion PCR) and 40 s at 72 uC. Finally, the two fragments were cleaved with EcoRI and XbaI and ligated into the pcDNA3.1myc/His plasmid.
Verification of the predicted TMD. Several fragments of truncated m164 were cloned 59 of the EGFP-coding sequence in the pEGFP-N1 vector (GenBank accession no. U55762; catalogue no. 6085-1; Clontech) via EcoRI and BamHI: (i) the complete m164 fragment fA-TMD-fB was amplified with the primers m164_for and B_rev. (ii) The fA-fB fragment lacking TMD was generated via site-directed mutagenesis by overlap-extension PCR with the primers m164_for and half1_rev, as well as half2_for and B_rev. In the subsequent fusion reaction, primers m164_for and B_rev were used. (iii) Fragment fA, including the signal peptide sequence but no TMD, was amplified with primers m164_for and A_rev. (iv) The TMD-fB fragment was amplified with primers TMD_B_N-terminal_for and TMD_B_N-terminal_rev. (v) The fB fragment lacking TMD was amplified with the primers B_noTMD_for and TMD_B_N-terminal_rev. (vi) For cloning of fragment TMD-fB39 into the pEGFP-C1 vector (catalogue no. 6084-1; Clontech), it was amplified by using the primers TMD_B_C-terminal_for and TMD_B_C-terminal_rev. (vii) For cloning the TMD fragment into the pEGFP-C1 vector, it was amplified by using the primers TMD_B_C-terminal_for and TMD_rev.
HA-tagged recombinant bacterial artificial chromosome (BAC) clones of mCMV. For generating recombinant virus mCMVm164HA-C, homologous recombination of linear PCR fragments with full-length mCMV BAC plasmid pSM3fr (Messerle et al., 1997; Wagner et al., 1999) was performed in Escherichia coli strain DH10B (Wagner et al., 2002) . The linear fragments for recombination were generated by touch-down PCR (Wagner & Koszinowski, 2004) with ProofStart Taq DNA polymerase (catalogue no. 202205; Qiagen) using primer pair m164-39HA-FRT-rev_MM and m164-39HA-FRTfor_MM. Recombinant BAC plasmid DNA was isolated from smallscale cultures and purified (Simon et al., 2006) . Physical integrity of the recombinant mCMV BAC genomes was confirmed by restrictionenzyme cleavage patterns, and correct mutagenesis was verified by Southern blot analysis with a tag (HA)-specific probe as well as by sequencing.
Preparation of cell lysates, subcellular fractionation and Western blotting. Protein expression was monitored by Western blot analysis of the total protein content of cell lysates (Holtappels et al., 2008) ) and cycloheximide (100 mg ml
21
) were used to block transcription and translation, respectively, in infected MEFs [for method, see Podlech et al. (2002) ]. Detection of m164 protein species was performed with polyclonal affinity-purified rabbit antibodies directed against a 25 aa C-terminal peptide (Holtappels et al., 2006) , whereas mouse monoclonal antibodies (mAbs) CROMA 101 and CROMA 103 (kindly provided by S. Jonjic, Rijeka, Croatia) were used for detecting mCMV proteins IE1 and E1, respectively. Mouse mAbs anti-HA (catalogue no. MMS-101R; HISS Diagnostics) and anti-V5 (catalogue no. R960-25; Invitrogen) served to detect the HA-tagged and V5-tagged proteins, respectively. Velocitycontrolled sucrose-gradient subcellular fractionation was accomplished with established procedures (Waugh et al., 2003) . ER-related fractions were identified with polyclonal rabbit anti-furin antibodies (catalogue no. PA1-062; Affinity Bioreagents) and mouse mAb anti-calnexin (catalogue no. MA3-027; Affinity Bioreagents).
Deglycosylation using Endo H and PNGase F. Total protein lysate from MEFs infected with mCMV-WT.Smith was prepared 6 h post-infection. For deglycosylation, 60 mg protein lysate was digested with either Endo H (catalogue no. P0702S; NEB) or PNGase F (catalogue no. P0704S; NEB). For a control, 60 mg protein lysate was incubated in absence of the enzymes. Enzyme reactions were stopped by adding SDS sample buffer. Finally, the samples were analysed by Western blot analysis.
CLSM analyses. The intracellular localization of gp36.5/m164 and of various subcellular markers was visualized by CLSM immunofluorescence analysis as described elsewhere (Holtappels et al., 2008) . Primary antibodies included the m164 C-terminal peptide-specific rabbit antibodies (see above), an ER-specific antibody directed against calnexin (mouse mAb; catalogue no. ab2798; Abcam), a Golgi-specific antibody directed against GM130 (mouse mAb; catalogue no. 610822; BD Transduction Laboratories) and antibodies directed against the INM protein emerin (rabbit polyclonal antibodies; catalogue no. BP4518; Acris). As secondary antibodies, Alexa Fluor 488-conjugated goat anti-mouse antibody (catalogue no. A11001; Molecular Probes) and Alexa Fluor 546-conjugated goat anti-rabbit antibody (catalogue no. A11010; Molecular Probes) were used. Immunofluorescence was examined with a Zeiss laser-scanning microscope (LSM 510) using the Multi Track function for image acquisition. The detailed microscope parameters chosen for image acquisition are available on request.
FRAP analysis. COS-7 cells were transiently transfected with expression plasmid EGFP-gp36.5/m164, which is equivalent to fA-TMD-fB-EGFP, in ibidi m-Slides VI (catalogue no. 80606; ibidi). Shortly before the measurements, the slides were rinsed with KHM buffer (110 mM potassium acetate, 2 mM magnesium chloride, 20 mM HEPES, pH 7.0). Images were taken with a Zeiss LSM 510 meta confocal microscope at 37 uC under an atmosphere of 5 % CO 2 using a Zeiss Plan Neo-Fluar 4061.3 N.A./DIC objective. For bleaching and imaging of EGFP, the 488 nm line of the argon laser (Lasos, LGK 7812 ML4, 30 mW) was used. Before the region of interest was bleached, 10-20 prebleach images were recorded. Bleaching was performed in a single scan with a bleaching intensity set to 100 % of the maximum output power of the laser and 50 % transmission of the acousto-optical tunable filter. For imaging, the laser intensity was reduced until no photobleaching could be detected during the imaging process, and 200-300 post-bleach images were recorded with a cycle time between 100 and 500 ms until no further change in the bleached area could be detected. The intensity of the bleached area was normalized and plotted against the acquisition time. The calculation of the diffusion coefficient D and of the immobile fraction was done with software Origin (version 7.5G; OriginLab Corporation) using the formula described by Ellenberg et al. (1997) .
Bioinformatic predictions. The following servers were employed: NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/) for N-glycosylation sites, PHDhtm (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat. pl?page=/NPSA/npsa_htm.html) (Combet et al., 2000; Rost et al., 1996) for transmembrane regions, and Phobius (http://phobius.sbc.su.se/) (Käll et al., 2007) for topology.
